Sangamo Therapeutics Inc
SGMO
Market Cap$163.66M
Close$
$2.35
226.1% upside
Current Fair Value
226.1% upsideUndervalued by 226.1% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $163.66 Million |
|---|---|
| Enterprise Value | $159.86 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.49 |
| Beta | 1.58 |
| Outstanding Shares | 210,185,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -1.56 |
|---|---|
| PEG | 1.42 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 3.06 |
| Enterprise Value to EBIT | -1.22 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.24 |
| Debt to Equity | 1.67 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Sangamo Therapeutics Inc
CEO: Alexander Macrae